Quadrature Capital LTD Macrogenics Inc Transaction History
Quadrature Capital LTD
- $5.81 Trillion
- Q2 2025
A detailed history of Quadrature Capital LTD transactions in Macrogenics Inc stock. As of the latest transaction made, Quadrature Capital LTD holds 21,105 shares of MGNX stock, worth $32,923. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,105Holding current value
$32,923% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MGNX
# of Institutions
118Shares Held
52.5MCall Options Held
55.3KPut Options Held
35.9K-
Bellevue Group Ag Kuesnacht, V89.92MShares$15.5 Million0.27% of portfolio
-
Armistice Capital, LLC New York, NY5.96MShares$9.3 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$8.43 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.21MShares$6.57 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$5.07 Million0.02% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $95.9M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...